Human leukocyte antigen‐G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma (Q45061505)

9 December 2017

title

Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma (English)

1 reference

9 December 2017

Human leukocyte antigen‐G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma (English)

1 reference

esophageal squamous cell carcinoma

19 November 2024

main subject

1 reference

Aifen Lin

1 reference

9 December 2017

Xia Zhang

1 reference

9 December 2017

Wen-Jun Zhou

1 reference

9 December 2017

Yan-Yun Ruan

1 reference

9 December 2017

Dan-Ping Xu

1 reference

9 December 2017

Qing Wang

1 reference

9 December 2017

Wei-Hua Yan

1 reference

9 December 2017

language of work or name

English

0 references

publication date

26 February 2011

1 reference

full work available at URL

9 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.25807

1 reference

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.25807

19 November 2024

1 reference

International Journal of Cancer

19 November 2024

published in

1 reference

9 December 2017

volume

129

1 reference

9 December 2017

1 reference

9 December 2017

page(s)

1382-1390

1 reference

Tumor immunoediting and immunosculpting pathways to cancer progression.

9 December 2017

cites work

1 reference

Tumor microenvironment and immune escape

21 January 2018

1 reference

NK cells and cancer immunosurveillance.

21 January 2018

1 reference

Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance.

21 January 2018

1 reference

Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.

21 January 2018

1 reference

Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompati

21 January 2018

1 reference

HLA-G in human reproduction: aspects of genetics, function and pregnancy complications

21 January 2018

1 reference

The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments

21 January 2018

1 reference

Biology and functions of human leukocyte antigen-G in health and sickness

21 January 2018

1 reference

The role of peptide presentation in the physiological function of HLA-G.

21 January 2018

1 reference

HLA-G in cancer: a way to turn off the immune system

21 January 2018

1 reference

Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells.

21 January 2018

1 reference

Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer

21 January 2018

1 reference

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes

21 January 2018

1 reference

HLA-G suppresses proliferation of CD4(+) T-lymphocytes

21 January 2018

1 reference

Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism

21 January 2018

1 reference

Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G.

21 January 2018

1 reference

Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells.

21 January 2018

1 reference

Human leukocyte antigen-G and cancer immunoediting

21 January 2018

1 reference

Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma

21 January 2018

1 reference

Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection

21 January 2018

1 reference

HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro

21 January 2018

1 reference

Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma

21 January 2018

1 reference

21 January 2018

Cancer statistics, 2009

1 reference

Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma

21 January 2018

1 reference

HLA-G-dependent suppressor cells: Diverse by nature, function, and significance.

21 January 2018

1 reference

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

21 January 2018

1 reference

HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression.

21 January 2018

1 reference

Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release

21 January 2018

1 reference

Tumor-specific upregulation of human leukocyte antigen-G expression in bladder transitional cell carcinoma

21 January 2018

1 reference

HLA-G: from biology to clinical benefits

21 January 2018

1 reference

Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis

21 January 2018

1 reference

HLA-G expression in human ovarian carcinoma counteracts NK cell function

19 November 2024

1 reference

Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation

19 November 2024

1 reference

Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8

19 November 2024

1 reference

Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer

19 November 2024

1 reference

Prognostic relevance of soluble human leukocyte antigen–G and total human leukocyte antigen class I molecules in lung cancer patients

19 November 2024

1 reference

The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer

19 November 2024

1 reference

HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia

19 November 2024

1 reference

Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer

19 November 2024

1 reference

Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression

19 November 2024

1 reference

Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma

19 November 2024

1 reference

HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract

19 November 2024

1 reference

Characterization of HLA-G expression in renal cell carcinoma

19 November 2024

1 reference

Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer

19 November 2024

1 reference

Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases

19 November 2024

1 reference

Total Soluble HLA Class I and Soluble HLA-G in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance

19 November 2024

1 reference

19 November 2024

Identifiers

DOI

10.1002/IJC.25807

1 reference

9 December 2017

1 reference